SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-24-008089
Filing Date
2024-02-14
Accepted
2024-02-14 20:51:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G ef20021768_sc13g.htm SC 13G 47511
  Complete submission text file 0001140361-24-008089.txt   49175
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Subject) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92543 | Film No.: 24641704
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 399 PARK AVENUE NEW YORK NY 10022
Business Address 399 PARK AVENUE NEW YORK NY 10022 212-287-6787
Blue Owl Capital Holdings LP (Filed by) CIK: 0001858703 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G